Expert Interview
A Third Look: Discussing the recent approval of ZURZUVAE (zuranolone) in treating women for postpartum depression (PPD) with a psychiatrist
Ticker(s): SAGEInstitution: Women's Wellness Psychiatry
-
majority of my practice is patients with perinatal and postpartum depression. I've treated hundreds of women with the condition.
-
familiar with the FDA approval of zuranolone (and did a podcast episode on the topic (https://www.buzzsprout.com/
1888285/episodes/13395212).
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
